A Kennett Square pharmacy must pay a $1 million civil penalty to resolve a state investigation that found it was producing and packaging thousands of doses of injectable weight loss drugs without ...

Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies The new class of GLP-1 medicines exemplifies both the ...

NEW YORK, Sept 8 (Reuters) - Ohio is taking steps to more tightly regulate how some large drug-compounding pharmacies in the state operate, including those making weight-loss drug copies, by limiting ...

In investing, compounding involves reinvesting the earnings an asset generates so they produce additional gains over time. Compounding is a powerful investment tool because it not only provides gains ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent implosion of Novo’s partnership with telehealth firm Hims & Hers suggests there is ...

When Chris Spears' pharmacy didn't have the obesity drug his doctor prescribed in 2023, he found another option while scrolling on Facebook. His feed was full of advertisements for alternatives to the ...

Forbes contributors publish independent expert analyses and insights. I write about investing, markets and Berkshire Hathaway. Berkshire Hathaway’s (BRK/A, BRK/B) Warren Buffett and his late partner ...

NEW YORK, May 20 (Reuters) - Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's (NOVOb.CO), opens new tab Wegovy as the U.S. drugs regulator ...

Empower Pharmacy, a Houston-based compounding pharmacy, has attracted media attention over the last decade for its rapid expansion in the region, with the company opening two large facilities that ...